Skip to main content

Advertisement

Log in

Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity

Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Aim-methods

ALARM-HF was a retrospective, observational registry that included 4,953 patients admitted for acute heart failure (AHF) in six European countries, Turkey, Mexico and Australia. Data about respiratory disorders and related medications were available for 4,616 patients with AHF.

Results

Chronic obstructive pulmonary disease (COPD) patients (n = 1,143, 24.8 %) were older and more frequently men (p < 0.001) when compared to non-COPD patients. Despite the equivalent left ventricular ejection fraction (38.6 ± 13.7 vs. 38.2 ± 14.5 %, p > 0.05), COPD patients more frequently presented with acutely decompensated heart failure (p < 0.001). Moreover, a worse cardiovascular profile was observed in the COPD group, including more atrial fibrillation/flutter, diabetes, hypertension, obesity, peripheral vascular disease (p < 0.001). Before admission, a higher percentage of COPD patients had experienced infections (25.0 vs. 14.0 %, p < 0.001), and were more likely to receive diuretics (p = 0.006), ACE inhibitors (p = 0.042), nitrates (p = 0.003), and digoxin (p = 0.034). With the exception of ACE inhibitors, those differences maintained at discharge, with concomitant increase in ARBs prescription (p = 0.01). Notably, β-blockers were less prescribed before admission (21.1 vs. 23.8 %, p = 0.055) in COPD patients, and remained underutilized at discharge (p < 0.001). Correcting for baseline differences, all-cause in-hospital mortality did not differ between COPD and non-COPD groups (10.1 vs. 10.9 %, p = 0.085).

Conclusion

A large proportion of AHF patients presented with concomitant COPD, had different clinical characteristics/co-morbidities, and less frequently received evidence-based pharmacological therapy compared to non-COPD patients. However, the in-hospital mortality was not higher in COPD group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Funk GC, Bauer P, Burghuber OC, Fazekas A, Hartl S, Hochrieser H, Schmutz R, Metnitz P (2012) Prevalence and prognosis of chronic obstructive pulmonary disease in critically Ill patients between 1998 and 2008. Eur Respir J [Epub ahead of print]

  2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442

    Article  CAS  PubMed  Google Scholar 

  3. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130–139

    Article  PubMed Central  PubMed  Google Scholar 

  4. Padeletti M, Jelic S, LeJemtel TH (2008) Coexistent chronic obstructive pulmonary disease and heart failure in the elderly. Int J Cardiol 125:209–215

    Article  PubMed  Google Scholar 

  5. Kociol RD, Greiner MA, Hammill BG, Eapen ZJ, Fonarow GC, Klaskala W, Mills RM, Curtis LH, Hernandez AF (2012) B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. Am Heart J 163:994–1001

    Article  CAS  PubMed  Google Scholar 

  6. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo, Abraham WT, Berkowitz RL, Galvao M, Horton DP, ADHERE Scientific Advisory Committee and Investigators (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209–216

    Article  PubMed  Google Scholar 

  7. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O’Connor CM, Yancy CW, Young J (2004) Organized program to initiate life saving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J 148:43–51

    Article  PubMed  Google Scholar 

  8. Mentz RJ, Fiuzat M, Wojdyla DM, Chiswell K, Gheorghiade M, Fonarow GC, O’Connor CM (2012) Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF. Eur J Heart Fail 14:395–403

    Article  PubMed  Google Scholar 

  9. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J (2003) The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24:464–474

    Article  CAS  PubMed  Google Scholar 

  10. Nieminen, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L, on behalf of the EuroHeart Survey Investigators (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27:2725–2736

    Article  PubMed  Google Scholar 

  11. Zannad F, Mebazaa A, Juillière Y, Cohen-Solal A, Guize L, Alla F, Rougé P, Blin P, Barlet MH, Paolozzi L, Vincent C, Desnos M, Samii K, for the EFICA Investigators (2006) Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail 8:697–705

    Article  PubMed  Google Scholar 

  12. Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, Porcu M (2006) Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 27:1207–1215

    Article  PubMed  Google Scholar 

  13. Follath F, Yilmaz MB, Delgado JF, Parissis JT, Porcher R, Gayat E, Burrows N, McLean A, Vilas-Boas F, Mebazaa A (2011) Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF). Intensive Care Med 37:619–626

    Article  CAS  PubMed  Google Scholar 

  14. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dichstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thegesen K (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of Cardiology. Eur Heart J 26:384–416

    Article  PubMed  Google Scholar 

  15. Parissis JT, Ikonomidis I, Rafouli-Stergiou P, Mebazaa A, Delgado J, Farmakis D, Vilas-Boas F, Paraskevaidis I, Anastasiou-Nana M, Follath F (2011) Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fraction. Am J Cardiol 107:79–84

    Article  PubMed  Google Scholar 

  16. Mebazaa A, Parissis J, Porcher R, Gayat E, Nikolaou M, Boas FV, Delgado JF, Follath F (2011) Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Int Care Med 37:290–301

    Google Scholar 

  17. Böhm M, Link A, Cai D, Nieminen MS, Filippatos GS, Salem R, Cohen Solal A, Huang B, Padley RJ, Kivikko M, Mebazaa A (2011) Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the survival of patients with acute heart failure in need of intravenous inotropic support trial. Crit Care Med 39:940–944

    PubMed  Google Scholar 

  18. Page RL 2nd, Lindenfeld J (2012) The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient. Curr Cardiol Rep 14:276–284

    Article  PubMed  Google Scholar 

  19. Hawkins NM, Jhund PS, Simpson CR, Petrie MC, Macdonald MR, Dunn FG, Macintyre K, McMurray JJ (2010) Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. Eur J Heart Fail 12:17–24

    Article  PubMed  Google Scholar 

  20. Barnes PJ (2010) Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med 7:e1000220

    Article  PubMed Central  PubMed  Google Scholar 

  21. Suskovic S, Kosnik M, Lainscak M (2010) Heart failure and chronic obstructive pulmonary disease: two for tea or tea for two? World J Cardiol 2:305–307

    Article  PubMed Central  PubMed  Google Scholar 

  22. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B, BODE Collaborative Group (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186:155–161

    PubMed  Google Scholar 

  23. Kollert F, Muller C, Tippelt A, Jorres RA, Heidinger D, Probst C, Pfeifer M, Budweiser S (2011) Anaemia in chronic respiratory failure. Int J Clin Pract 65:479–486

    Article  CAS  PubMed  Google Scholar 

  24. Huertas A, Palange P (2011) COPD: a multifactorial systemic disease. Ther Adv Respir Dis 5:217–224

    Article  CAS  PubMed  Google Scholar 

  25. Corsonello A, Antonelli Incalzi R, Pistelli R, Pedone C, Bustacchini S, Lattanzio F (2011) Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med 17 Suppl 1:S21–S28

    Article  PubMed  Google Scholar 

  26. Singh S, Loke YK, Enright P, Furberg CD (2012) Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax 68:114–116

    Article  PubMed  Google Scholar 

  27. Bhatt SP, Nanda S, Kintzer JS (2012) Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease. Respir Med 106:1134–1138

    Article  PubMed  Google Scholar 

  28. Fuschillo S, Martucci M, Donner CF, Balzano G (2012) Airway bacterial colonization: the missing link between COPD and cardiovascular events? Respir Med 106:915–923

    Article  PubMed  Google Scholar 

  29. Medina AM, Marteles MS, Sáiz EB, Martínez SS, Laiglesia FR, Rodríguez JA, Pérez-Calvo JI (2011) Prognostic utility of NT-proBNP in acute exacerbations of chronic pulmonary diseases. Eur J Intern Med 22:167–171

    Article  CAS  PubMed  Google Scholar 

  30. Taylor DM, Fui MN, Chung AR, Gani L, Zajac JD, Burrell LM (2012) A comparison of precipitants and mortality when acute decompensated heart failure occurs in the community and hospital settings. Heart Lung Circ 21:439–443

    Article  PubMed  Google Scholar 

  31. Rudiger A, Streit M, Businger F, Schmid ER, Follath F, Maggiorini M (2010) The impact of infections on critically ill acute heart failure patients: an observational study. Swiss Med Wkly 18(140):w13125

    Google Scholar 

  32. O’Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M (2005) Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail 11:200–205

    Article  PubMed  Google Scholar 

  33. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J 33:1787–1847

    Article  PubMed  Google Scholar 

  34. Mainguy V, Girard D, Maltais F, Saey D, Milot J, Sénéchal M, Poirier P, Provencher S (2012) Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease. Am J Cardiol 110:258–263

    Article  CAS  PubMed  Google Scholar 

  35. Ekman I, Andersson G, Boman K, Charlesworth A, Cleland JG, Poole-Wilson P, Swedberg K (2006) Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial. Patient Educ Couns 61:348–353

    Article  PubMed  Google Scholar 

  36. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 261:887–894

    Google Scholar 

  37. Guazzi M (2003) Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role. Chest 124:1090–1102

    Article  PubMed  Google Scholar 

  38. Staszewsky L, Wong M, Masson S, Barlera S, Carretta E, Maggioni AP, Anand IS, Cohn JN, Tognoni G, Latini R (2007) Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial. J Card Fail 13:797–804

    Article  CAS  PubMed  Google Scholar 

  39. Sin DD, Man SF (2005) Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 83:8–13

    CAS  PubMed  Google Scholar 

  40. Rusinaru D, Saaidi I, Godard S, Mahjoub H, Battle C, Tribouilloy C (2008) Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. Am J Cardiol 101:353–358

    Article  PubMed  Google Scholar 

  41. Macchia A, Monte S, Romero M, D’Ettorre A, Tognoni G (2007) The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail 9:942–948

    Article  PubMed  Google Scholar 

  42. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM (2005) The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165:55–61

    Article  PubMed  Google Scholar 

  43. Blum A, Simsolo C, Sirchan R, Haiek S (2011) “Obesity paradox” in chronic obstructive pulmonary disease. Isr Med Assoc J 13:672–675

    PubMed  Google Scholar 

  44. Arnaudis B, Lairez O, Escamilla R, Fouilloux A, Fournier P, Monteil B, Bouisset F, Arnal JF, Elbaz M, Carrié D, Roncalli J, Pathak A, Galinier M (2012) Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure. Clin Res Cardiol 101:717–726

    PubMed  Google Scholar 

  45. Steinacher R, Parissis JT, Strohmer B, Eichinger J, Rottlaender D, Hoppe UC, Altenberger J (2012) Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure. Clin Res Cardiol 101:637–645

    PubMed  Google Scholar 

  46. Caglar IM, Dasli T, Turhan Caglar FN, Teber MK, Ugurlucan M, Ozmen G (2012) Evaluation of atrial conduction features with tissue Doppler imaging in patients with chronic obstructive pulmonary disease. Clin Res Cardiol 101:599–606

    PubMed  Google Scholar 

Download references

Conflict of interest

JP, AM, FF received research Grants from Abbott USA and Orion Pharma, Finland.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John T. Parissis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parissis, J.T., Andreoli, C., Kadoglou, N. et al. Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity. Clin Res Cardiol 103, 733–741 (2014). https://doi.org/10.1007/s00392-014-0708-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-014-0708-0

Keywords

Navigation